News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,057 Results
Type
Article (40430)
Company Profile (310)
Press Release (654317)
Section
Business (206097)
Career Advice (1998)
Deals (35689)
Drug Delivery (91)
Drug Development (82165)
Employer Resources (168)
FDA (16253)
Job Trends (14957)
News (348505)
Policy (32710)
Tag
Academia (2570)
Alliances (49954)
Alzheimer's disease (1255)
Approvals (16187)
Artificial intelligence (150)
Bankruptcy (353)
Best Places to Work (11703)
Biotechnology (224)
Breast cancer (190)
Cancer (1376)
Cardiovascular disease (106)
Career advice (1666)
Cell therapy (280)
Clinical research (65636)
Collaboration (453)
Compensation (248)
COVID-19 (2552)
C-suite (111)
Data (1367)
Diabetes (163)
Diagnostics (6243)
Earnings (85421)
Employer resources (146)
Events (111780)
Executive appointments (367)
FDA (16889)
Funding (413)
Gene therapy (193)
GLP-1 (599)
Government (4360)
Healthcare (18922)
Infectious disease (2641)
Inflammatory bowel disease (112)
Interviews (309)
IPO (16457)
Job creations (3652)
Job search strategy (1422)
Layoffs (429)
Legal (7887)
Lung cancer (199)
Manufacturing (195)
Medical device (13256)
Medtech (13261)
Mergers & acquisitions (19365)
Metabolic disorders (434)
Neuroscience (1569)
NextGen Class of 2024 (6566)
Non-profit (4501)
Northern California (1646)
Obesity (253)
Opinion (186)
Patents (114)
People (57089)
Phase I (20473)
Phase II (28887)
Phase III (21566)
Pipeline (509)
Postmarket research (2591)
Preclinical (8671)
Radiopharmaceuticals (248)
Rare diseases (254)
Real estate (5950)
Regulatory (21845)
Research institute (2359)
Resumes & cover letters (349)
Southern California (1430)
Startups (3627)
United States (14866)
Vaccines (570)
Weight loss (178)
Date
Today (92)
Last 7 days (688)
Last 30 days (2768)
Last 365 days (35777)
2024 (34874)
2023 (40498)
2022 (51695)
2021 (56235)
2020 (54543)
2019 (47059)
2018 (35456)
2017 (32656)
2016 (32027)
2015 (38064)
2014 (31749)
2013 (26719)
2012 (28926)
2011 (29660)
2010 (27609)
Location
Africa (722)
Arizona (194)
Asia (37975)
Australia (6203)
California (3713)
Canada (1411)
China (295)
Colorado (167)
Connecticut (171)
Europe (82356)
Florida (513)
Georgia (130)
Illinois (377)
Indiana (218)
Kansas (97)
Maryland (621)
Massachusetts (2939)
Michigan (169)
Minnesota (288)
New Jersey (1067)
New York (1050)
North Carolina (739)
Northern California (1646)
Ohio (144)
Pennsylvania (906)
South America (1103)
Southern California (1430)
Texas (531)
Utah (105)
Washington State (392)
695,057 Results for "curelab oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
CureLab Oncology Files Patent Application for Groundbreaking Wound-Healing Therapy
CureLab Oncology, a clinical-stage biotech company, has filed a patent application with worldwide potential for a revolutionary wound-healing therapy based on its p62/SQSTM1 DNA plasmid.
June 27, 2024
·
2 min read
Press Releases
CureLab Oncology Appoints Dr. Aubrey C. Galloway as Chief Medical Officer
July 11, 2024
·
3 min read
Genetown
CureLab Receives $3M from Prominent Biotech Investor Dr. John Ballantyne
The co-founder of Aldevron, Dr. John Ballantyne, has invested $3M in CureLab Oncology and CureLab Veterinary.
March 2, 2023
·
3 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
November 25, 2024
·
7 min read
Press Releases
Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program
December 5, 2024
·
6 min read
Press Releases
OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology
November 21, 2024
·
4 min read
Press Releases
Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals
October 24, 2024
·
5 min read
Bladder cancer
Protara, CG Oncology Tout Promising Bladder Cancer Outcomes
Protara is advancing a cell therapy that triggers both adaptive and innate antitumor immune responses, while CG Oncology’s approach makes use of an oncolytic immunotherapy that preferentially targets cancer cells and proliferates inside them, destroying them from the inside.
December 6, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR™ (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
September 5, 2024
·
14 min read
Press Releases
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors
November 11, 2024
·
18 min read
1 of 69,506
Next
